- Home
- ASPI vs JYNT Comparison
ASPI vs JYNT Comparison
Compare ASPI & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPI
- JYNT
- Stock Information
- Founded
- ASPI 2021
- JYNT 2010
- Country
- ASPI United States
- JYNT United States
- Employees
- ASPI N/A
- JYNT N/A
- Industry
- ASPI Major Chemicals
- JYNT Multi-Sector Companies
- Sector
- ASPI Industrials
- JYNT Miscellaneous
- Exchange
- ASPI Nasdaq
- JYNT Nasdaq
- Market Cap
- ASPI 158.4M
- JYNT 179.2M
- IPO Year
- ASPI 2022
- JYNT 2014
- Fundamental
- Price
- ASPI $8.41
- JYNT $11.48
- Analyst Decision
- ASPI Strong Buy
- JYNT Strong Buy
- Analyst Count
- ASPI 2
- JYNT 2
- Target Price
- ASPI $4.50
- JYNT $18.00
- AVG Volume (30 Days)
- ASPI 7.2M
- JYNT 41.0K
- Earning Date
- ASPI 11-19-2024
- JYNT 11-07-2024
- Dividend Yield
- ASPI N/A
- JYNT N/A
- EPS Growth
- ASPI N/A
- JYNT N/A
- EPS
- ASPI N/A
- JYNT N/A
- Revenue
- ASPI $2,295,679.00
- JYNT $120,071,078.00
- Revenue This Year
- ASPI $1,760.86
- JYNT $0.70
- Revenue Next Year
- ASPI $314.74
- JYNT N/A
- P/E Ratio
- ASPI N/A
- JYNT N/A
- Revenue Growth
- ASPI N/A
- JYNT 7.46
- 52 Week Low
- ASPI $1.09
- JYNT $7.31
- 52 Week High
- ASPI $9.23
- JYNT $17.82
- Technical
- Relative Strength Index (RSI)
- ASPI 74.74
- JYNT 61.97
- Support Level
- ASPI $6.40
- JYNT $10.95
- Resistance Level
- ASPI $8.86
- JYNT $12.18
- Average True Range (ATR)
- ASPI 0.97
- JYNT 0.27
- MACD
- ASPI 0.22
- JYNT 0.08
- Stochastic Oscillator
- ASPI 71.27
- JYNT 75.61
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.